Abstract
Objectives The objective of this review was to evaluate the diagnosis and treatment of advanced and delayed sleep-wake phase disorders (ASWPD, DSWPD), both forms of circadian rhythm sleep-wake disorders (CRSWDs) using both human reviewers and ChatGTP to summarize relevant content.
Methods PubMed-Medline, EbscoHost, and Web of Science were searched for peer reviewed articles. Original research articles published in English were searched for full-text studies. Studies that reported quantitative data on ASWPD and DSWPD diagnosing tools and treatment options in individuals of all ages were assessed. We assessed ChatGTP 4.0’s capacity to extract and summarize data from these studies and evaluated it alongside human reviewers.
Results Our review of 49 articles on CRSWD from the past 20 years found that 91% focused on DSWPD. The most common diagnostic tools were the MEQ, MCQ, Pittsburgh Sleep Quality Index, and Epworth Sleepiness Scale, with primary methods including actigraphy and dim-light-melatonin-onset. Melatonin, often combined with light therapy and CBT, was the predominant treatment. ChatGPT-4.0 facilitated the review process with about 92% accuracy but required manual oversight for optimal results.
Conclusions Our review identified key diagnostic tools, such as MEQ and MCQ surveys, and common treatment options for ASWPD and DSWPD, including melatonin, light therapy, and CBT. The findings underscore the need for comprehensive and individualized treatment approaches for CRSWDs, with a particular focus on expanding research on ASWPD and increasing data representation across age groups. While ChatGPT shows potential in streamlining data extraction for CRSWDs, it still requires human oversight to ensure accuracy.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This is a systematic review thus the source of the data is other publicly available data
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
All authors declare that they have no financial support or conflicts of interest related to this work. There is no off-label or investigational use of products discussed in the manuscript. The authors confirm that this manuscript does not report on a clinical trial. All authors have reviewed and approved the final manuscript for submission.
Data Availability
All data produced in the present work are contained in the manuscript
